Top Biotechnology Companies in New-Zealand

The Biotechnology Industry in New Zealand has been growing at a steady pace in recent years, driven by a combination of factors, including government support, a skilled workforce, and a strong research base. In this article, we will explore the key statistics from 2022, factors contributing to its growth and success, industry growth and comparison to previous years, key trends including technological disruptions, challenges, and future outlook.

read full article below
Filter bySearch by company name, registration number or domain name
CompanyHeadcountContactDescriptionDecision Maker
QUANTEC LIMITED9 +64 274 533 922
info@quantec.co.nz

Quantec is a New Zealand company focused on harnessing natures solutions to improve health. Established in 2009, Quantec specialises in identifying and extracting high-performance bioactives from natural products. Supported by extensive research and clinical testing, these bioactives are developed into proprietary ingredient formulations for human and animal health applications. With expertise in chemistry, microbiology, animal science, physiology and engineering, we have a proven track record of taking novel, award-winning products to market. In 2018 and 2019, Quantec was awarded the Natural Health Products NZ Supreme Award, becoming New Zealands first ever back-to-back winner. Quantec discovered and patented IDP®, its novel milk fraction, which has proven bioactive properties. More on IDP® IDP® is derived from some of the highest quality milk in the world, and supports the immune system by providing natural protection from free radicals, inflammation and infection. - An all-…

BIOVIROS4 +64 21 402 487
info@bioviros.com

BioViros is a biotech company providing resources for regenerative medicine. Supported by Bridgewest Ventures and Callaghan Innovation, we strive to innovate and improve gene therapies, and make the bench to bed journey faster and cheaper for people that need life-saving treatments.

NZCR186 +64 9 373 3474
info@nzcr.co.nz

New Zealand Clinical Research (NZCR) was formed in mid 2020 by the merger of Auckland Clinical Studies (ACS) and Christchurch Clinical Studies Trust (CCST). NZCR creates a stronger global player formed by bringing together two innovative and highly respected early phase clinical research units. NZCR is the result of over 34 years of combined research experience and brings expanded scale and capabilities. NZCR allows further development of the New Zealand clinical research infrastructure with the promise of delivering better treatment options for patients in New Zealand and around the world.

MITOQ LIMITED55 +64 9 379 8222
customerservice@mitoq.com

At MitoQ, were looking to change the world for the better - one cell at a time. We created a pioneering cell health technology that is backed by decades of global scientific research. MitoQ was invented in New Zealand and were still headquartered here by Aucklands beautiful Waitematā Harbour. Were proud of our Kiwi culture. Were honest, curious, collaborative and positive. We love seeing other people energized to succeed. MitoQ is for everybody, so youll find our team and distribution centers all over the world including the US, China and Europe. We ship to more than 140 countries so if you dont see yours in the shop, contact us - weve always loved a challenge.

LINCOLN AGRITECH LIMITED76 +64 7 858 4840
info@lincolnagritech.co.nz

Established in 1964, Lincoln Agritech Ltd is a multidisciplinary research and development company owned by Lincoln University. We deliver leading-edge science and engineering for the environment, agriculture and industry. Our passion is to inquire and innovate, to drive science and engineering research to create new knowledge and technologies that enable our clients and stakeholders to prosper. Our work is funded through a combination of government-funded science programmes, contract research, and consultancy; examples of our work can be found throughout New Zealand and internationally: IRRICAD – Irrigation design software. IRRICAD is a world-leading design software program, specifically developed for the irrigation industry by Lincoln Agritech. Launched in 1988, today IRRICAD is distributed globally and sold to over 85 countries. Hydrometrics GW50 – Optical Groundwater Nitrate Sensor. Lincoln Agritech has developed a low-cost sensor that measures the concentration of nitrates in …

MINT INNOVATION51 (blank)
hello@mint.bio

Mint Innovation, a New Zealand cleantech company, has scaled biological processes that recover valuable metals from waste. Our first process is a unique biometallurgical approach to recover metals from electronic scrap. A key aspect of the Mint process is the use of proprietary microbes that are selective for specific metals. Combined with the advantages of low-cost green chemistry, we aim to make it viable, both economically and environmentally, to capture value from e-waste near its point of collection.

SCION439 +64 3 363 0910
enquiries@scionresearch.com

Scion is the leading New Zealand Crown Research Institute in the areas of: • Sustainable forest management and tree improvement. • Forestry biosecurity, risk management and mitigation. • Wood processing, wood-related bioenergy, waste streams and other biomaterials. • Forestry and forestry-based ecosystem services to inform land-use decision making. Scion collaborates with other research providers and end-users to develop: • Land-based biosecurity, soil and freshwater management. • Climate change adaptation and mitigation. • Indigenous forestry. • Industrial biotechnology and high-value manufacturing.

UC SCIENCE(blank) +64 3 369 3999
info@canterbury.ac.nz

The Faculty of Science at the University of Canterbury delivers high quality learning through teaching that builds on our research excellence. Located in the spectacular South Island of New Zealand, UC Science offers a broad range of undergraduate and postgraduate qualifications, state-of-the-art facilities, amazing research opportunities, passionate, world-recognised lecturers and an unrivaled student experience. The College includes the School of Physical and Chemical Sciences, School of Biological Sciences, the Departments of Communication Disorders, Geography, Geological Sciences, Psychology, the Waterways Centre for Freshwater Management and the Gateway Antarctica Research Centre. UC Science arms students with the knowledge and transferable skills to make a real difference in society. Join the dreamers, explorers and innovators of our time. Choose Science and change the world.

CAWTHRON INSTITUTE220 +64 3 548 2319
info@cawthron.org.nz

Cawthron Institute is New Zealands largest independent science organisation, offering a broad spectrum of services to help protect the environment and support sustainable development of primary industries. Based in the Nelson Tasman region, Cawthron works with regional councils, government departments, major industries, private companies, and other research organisations throughout New Zealand and around the world. Cawthron is a diverse organisation employing more than 250 scientists, laboratory technicians, researchers and specialist staff from 26 countries. Cawthrons scientists have expertise in aquaculture research, marine and freshwater resource management, food safety and quality, algal technologies, biosecurity and analytical testing. Its ground-breaking science is supported by substantial testing and research laboratories, state-of-the-art technology and a purpose-built aquaculture park. Cawthrons Aquaculture Park also houses a recently-opened Finfish Research Centre designe…

GENEIOUS23 (blank)
(blank)

In the past decade, the digitization of biological research has accelerated, and the science of biology has increasingly moved from the lab to the computer. Geneious aims to ease that process for scientists, allowing them to stay focused on science, while software handles the data management. Geneious creates powerful, integrated and visually appealing bioinformatics solutions, with a strong emphasis on ease of use and overall user experience. We are the market leaders in bioinformatics, constantly iterating and innovating to ensure our software solutions deliver everything our customers need. Headquartered in New Zealand with users in 125 countries worldwide, Geneious solutions enhance productivity in more than 4,000 universities, research institutes and businesses. In 2022, Geneious became part of Dotmatics, the worlds largest and most powerful scientific R&D software platform. Combining an open data informatics framework with best in breed applications like Geneious Prime and Ge…

JH LAW1 +64 27 722 7766
janey@jhlaw.nz

JH LAW is a law firm founded in 2021 by Janey Haringa. The firm operates NZ-wide (Janey works remotely from the Waikato). She is a corporate & commercial lawyer helping kiwi businesses to buy or sell property, shares or assets. She also specialises in assisting investors or helping businesses raise capital. Reach out to Janey via LinkedIn messenger or email janey@jhlaw.nz. Our website also has further general information about services & fee estimates.

MEDIRAY NZ26 +64 800 106 100
service@mediray.co.nz

Mediray distributes high quality laboratory and medical supplies to Kiwi businesses, institutions and consumers. Whether youre involved in industry, research, healthcare or diabetes management, our aim is to help you along the way by giving you the tools you need to achieve your goals and solve your problems. We distribute across New Zealand for some of the biggest names in science, including bioMérieux, Eppendorf, PerkinElmer, Abbott Laboratories, BioLegend, Takara, Hanna Instruments and Macherey-Nagel. From common consumables and reagents, to complex scientific instrumentation, our diverse portfolio always has options to offer. You can start browsing at www.mediray.co.nz

TAYLORED HEALTH & EXECUTIVE PERFORMANCE7 +64 7 834 0002
hello@tayloredhealth.co.nz

We are an award-winning, integrative and data-driven health hub, offering personalised “whole health” wellness programs and services to New Zealand. We do this by deeply understanding the people who come to us, and delivering exceptional service through a team of 8 multi-disciplinary specialties, all under one roof. Through the use of cutting edge techniques, unconventional systems, real-time diagnostics and innovative biotechnology, we work with some of the worlds best athletes and business leaders, including the New Zealand All Blacks and well-known CxOs from Multi-National Companies (MNCs). Headquartered in New Zealand, the Taylored Hub is a 4,300 ft2 facility fitted out with modern exercise equipment, IoT-based devices, and automation with a growing tribe of people seeking whole health for a long, vibrant and productive healthspan.

DNAITECH LTD3 +64 21 429 962
murray@dnaitech.com

DNAiTECH was founded in 2020 and is located in sunny Marlborough, Aotearoa-New Zealand. Marlborough is New Zealands largest wine growing area. But DNAiTECH is adding a new flavour to Marlborough, we are the first biotechnology company founded in Marlborough, we are focusing on biomedical diagnostics, environmental testing and education. Our DNAiTECH technology enables real-time isothermal amplification of nucleic acid. The DNAiTECH is powerful because it integrates a small portable instrument with the imaging and data processing power of the Smartphone. The instrument is operated by the Smartphone via Bluetooth, with the phone camera providing the optical sensing of the DNA amplification and the data collection and processing via a specialized app. DNAiTECH can be used for any isothermal method for nucleic acid amplification. DNAiTECH is cost effective, has low power requirements and can be operated remotely with its internal lithium ion batteries.

KERAPLAST8 +64 3 325 9100
privacy@keraplast.com

Keraplast is a world-leading biotechnology company that recovers bioactive keratin proteins from regeneratively farmed New Zealand wool. We are a global exporter, and we are proud partners of Croda International, AIDP Inc and IFF Health. Keratin is one of natures most important building blocks at a cellular level. It gives the human body structure and order, and is fundamental in the development of healthy tissues including skin, hair and nails. Using our proprietary Functional Keratin® platform technology, we recover soluble keratin proteins from wool fibres while controlling the protein molecular weight and cysteine availability. We then blend these proteins together to create ingredients that are 91% homologous to human keratin. Our unique, bioactive ingredients are used in the worlds leading beauty and personal care products. Our mission is to create life-changing ingredients for life-changing products. We are on our journey to becoming a regenerative business and we …

EQUINOX LABS4 +64 27 238 4981
info@equinoxlabs.co.nz

Equinox is a PPE distribution company. Focused on delivering the highest quality products to our valued customers and businesses.

BLUE PENGUIN IP(blank) +64 27 603 4305
mail@bpip.nz

Blue Penguin IP is a boutique Intellectual Property firm specializing in patents and patent strategy for biotechnology and chemistry inventions.

DAISY LAB6 (blank)
info@daisylab.co.nz

New Zealand is the largest exporter of dairy proteins. These exports deliver nutrition to those who need it and create prosperity for our farmers and our communities. Yet it also comes at a cost to our environment, polluting our waterways and generating substantial greenhouse gas emissions. What if there was another way? We believe there is. Using precision fermentation we can produce identical dairy proteins without the harm to our land, our rivers or our animals. Daisy Lab is on a mission to pioneer precision fermentation technology for dairy protein production.

NEW ZEALAND CLINICAL RESEARCH38 +64 9 373 3474
info@nzcr.co.nz

New Zealand Clinical Research (NZCR) was formed in mid 2020 by the merger of Auckland Clinical Studies (ACS) and Christchurch Clinical Studies Trust (CCST). NZCR creates a stronger global player formed by bringing together two innovative and highly respected early phase clinical research units. NZCR is the result of over 34 years of combined research experience and brings expanded scale and capabilities. NZCR allows further development of the New Zealand clinical research infrastructure with the promise of delivering better treatment options for patients in New Zealand and around the world.

MEDILINK (NZ) LTD1 +64 27 633 4546
jason@medilink.co.nz

MediLink is a New Zealand consultancy providing customer support services to clients in the medical device, pharmaceutical & biotechnology sectors ensuring business continuity. This includes customer relationship maintenance, staff transition support & procurement advice, addressing the needs of your customers when your staff move on. This enables you to retain your customers who may otherwise fall prey to your competition in the absence of a dedicated resource, increasing the chances of success of your new territory manager. Also, businesses new to the market in New Zealand can be matched with the right procurement partner at District Health Boards, private hospitals & Government procurement  agencies across the country to drive sales.

Top Biotechnology Companies in New-Zealand

Key Statistics from 2022

According to the latest data, the Biotechnology Industry in New Zealand has an estimated value of NZD 1.3 billion and employs around 4,000 people. In 2022, the industry is expected to grow by 5.2%, driven by an increase in research and development spending and a growing demand for biotech products. The GDP growth rate for the country is estimated to be around 4.5% in 2022, indicating a positive outlook for the industry.

Factors Contributing to its Growth and Success

One of the key factors contributing to the growth and success of the Biotechnology Industry in New Zealand is government initiatives aimed at promoting innovation and research in the field. The government has invested heavily in research infrastructure, including the establishment of research centers and the provision of funding for research projects. This has helped to attract leading researchers to the country and has fostered a strong research culture.

Another factor contributing to the growth of the industry is the availability of a skilled workforce. New Zealand has a strong education system, producing graduates with degrees in biotechnology, biochemistry, and related fields. This has helped to provide a pool of talent for the industry, and has enabled businesses to develop innovative products and solutions.

Industry Growth and Comparison to Previous Years

The Biotechnology Industry in New Zealand has shown consistent growth over the past few years, with an average growth rate of 4.8% between 2017 and 2021. The industry has been able to weather the challenges posed by the COVID-19 pandemic, with demand for biotech products remaining strong even during the lockdowns.

In comparison to previous years, the industry has shown significant growth in the healthcare segment, with a number of local businesses launching new products and treatments that cater to this growing trend. The agricultural biotechnology segment has also shown strong growth, with businesses developing innovative solutions to improve crop yields and reduce the use of pesticides.

Key Trends including Technological Disruptions

The Biotechnology Industry in New Zealand is witnessing several key trends that are shaping its future. One of the most significant trends is the increasing use of technology in the development and production of biotech products. Local businesses are investing in automated systems, such as robotics and artificial intelligence, to improve efficiency and reduce costs.

Another trend is the growing importance of genomics in the industry. Advances in genomics technology are enabling businesses to develop personalized treatments and therapies that are tailored to individual patients. This is revolutionizing the healthcare sector, and is expected to drive growth in the industry in the coming years.

Challenges

The Biotechnology Industry in New Zealand is facing several challenges that could impact its future growth. One of the key challenges is the limited size of the local market, which makes it difficult for businesses to achieve economies of scale. This has led some businesses to focus on export markets, which can be highly competitive.

Another challenge is the shortage of investment capital. While the government has provided some funding for research and development, private investment in the industry has been limited. This has made it difficult for businesses to develop and commercialize their products.

Future Outlook

Despite these challenges, the future outlook for the Biotechnology Industry in New Zealand is positive. The industry is expected to continue growing at a steady pace, driven by a strong research culture, a skilled workforce, and increasing demand for biotech products. The trend towards personalized medicine and treatments is also expected to continue, with businesses leveraging advances in genomics technology to develop innovative solutions.

To address the challenges facing the industry, the government and private sector need to work together to increase investment in research and development and promote entrepreneurship. This will help to attract more private investment to the industry, and enable businesses to develop and commercialize their products more effectively.

Conclusion

In conclusion, the Biotechnology Industry in New Zealand is a growing and dynamic sector, driven by a combination of government support, a skilled workforce, and a strong research base. While the industry faces several challenges, including limited investment capital and a small local market, the future outlook is positive. Businesses will need to continue to innovate and differentiate themselves to remain competitive in this market, and the government and private sector need to work together to promote entrepreneurship and increase investment in research and development. The Biotechnology Industry in New Zealand has the potential to become a major player in the global biotech industry, and the future looks bright for this exciting and innovative sector.

undefined's picture
By Melissa Goh
Published on 23 May 2023